|
ATXI
|
Avenue Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AVDL
|
Avadel Pharmaceuticals plc
|
US
|
NASDAQ
|
|
AZPN
|
Aspen Technology, Inc.
|
US
|
NASDAQ
|
|
AZTA
|
Azenta, Inc.
|
US
|
NASDAQ
|
|
BAD
|
B.A.D. ETF
|
US
|
AMEX
|
|
BCO
|
Brinks Company (The)
|
US
|
NYSE
|
|
BEAT
|
BioTelemetry, Inc.
|
US
|
NASDAQ
|
|
BLCO
|
Bausch + Lomb Corporation
|
US
|
NYSE
|
|
BLFS
|
BioLife Solutions, Inc.
|
US
|
NASDAQ
|
|
BMRA
|
Biomerica, Inc.
|
US
|
NASDAQ
|
|
BXRX
|
Baudax Bio, Inc.
|
US
|
NASDAQ
|
|
CALT
|
Calliditas Therapeutics AB
|
US
|
NASDAQ
|
|
CASI
|
CASI Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CBT
|
Cabot Corporation
|
US
|
NYSE
|
|
CDXS
|
Codexis, Inc.
|
US
|
NASDAQ
|
|
CG
|
The Carlyle Group L.P.
|
US
|
NASDAQ
|
|
CNTA
|
Centessa Pharmaceuticals plc
|
US
|
NASDAQ
|
|
CNTG
|
Centogene N.V.
|
US
|
NASDAQ
|
|
COLL
|
Collegium Pharmaceutical, Inc.
|
US
|
NASDAQ
|
|
CORT
|
Corcept Therapeutics Incorporated
|
US
|
NASDAQ
|